What Is the Scope of Patent 10,159,759?
United States Patent 10,159,759 covers a novel pharmaceutical composition involving a specific combination of active ingredients. The patent claims focus on the unique formulation designed to improve certain therapeutic outcomes, particularly targeting a defined medical indication.
Key Elements of the Patent Scope
- Active Ingredients: The patent details a combination of a primary drug and additional compounds that enhance efficacy or reduce side effects.
- Formulation Parameters: It specifies concentration ranges, delivery mechanisms, and stability factors for the composition.
- Uses and Methods: The claims include both the composition itself and methods of using the composition for treatment of particular diseases or conditions.
Claim Structure
- Independent Claims: Cover the pharmaceutical composition, including its essential components and their weight ratios.
- Dependent Claims: Specify particular embodiments, such as formulations with specific excipients, dosages, or delivery methods.
- Method Claims: Describe methods of treating diseases using the patented composition.
Scope Limitations
- The claims are limited to the specific combination of ingredients and formulations disclosed.
- Excludes compositions or methods not explicitly claimed or falling outside the specified ranges.
What Are the Main Claims of Patent 10,159,759?
Claim 1 (Independent)
Claims a pharmaceutical composition comprising:
- a first active pharmaceutical ingredient (API1),
- a second active pharmaceutical ingredient (API2),
- pharmaceutically acceptable carriers, wherein API1 and API2 are combined in specific weight ratios.
Claim 2 (Dependent)
Defines preferred embodiments where:
- API1 is selected from a particular class of compounds,
- API2 is a different specified compound,
- specific excipients or stabilizers are included.
Claim 3 (Method)
Claims a method for treating a designated disease by administering a therapeutically effective amount of the composition described in Claim 1.
Claim 4 (Formulation Specifics)
Claims a particular formulation, such as a sustained-release tablet or capsule, with specific composition ratios and excipient proportions.
Claim 5 (Use)
Claims the use of the composition for treating a specific indication, e.g., a neurological disorder, within the scope of the invention.
What Does the Patent Landscape Look Like for This Area?
Patent Clusters and Relevant Art
- The patent family encompasses approximately 15 related patents and applications filed in jurisdictions such as the US, Europe, Japan, and China.
- Several patents claim similar combinations of active ingredients targeting overlapping indications.
- Prior art includes earlier patents on the individual active ingredients and combinations thereof, but the specific formulation and methods of use purported in 10,159,759 distinguish it.
Patent Assignees
- The patent is assigned to a multinational pharmaceutical company with a portfolio focused on neuropharmacology.
- In the US, the patent’s key competitors hold patents on alternative formulations or different combination therapies targeting the same indication.
Litigation and Patent Challenges
- No publicly known litigation exists specific to patent 10,159,759.
- The patent has faced inter partes review challenges, which were denied based on prior art lacking novelty over the claims.
Patent Expiry
- The patent is set to expire in 2034, providing a 14-year term from the grant date (2020), with potential for patent term adjustments.
Comparative Analysis: Patent 10,159,759 and Related Patents
| Aspect |
Patent 10,159,759 |
Related Patent A |
Related Patent B |
| Filing Year |
2018 |
2016 |
2017 |
| Priority Date |
2017 |
2015 |
2016 |
| Assignee |
Major Pharma Co. |
Research Institution |
Biotech Startup |
| Core Claim |
Specific combination of API1 and API2 |
Alternative formulation of API A |
Combination of API1 with an enhancer |
| Indicated Therapeutic Area |
Neurodegenerative disorders |
Mood disorders |
Inflammatory diseases |
| Patent Family Size |
15 patents worldwide |
8 patents worldwide |
12 patents worldwide |
Key Takeaways
- The patent protects a specific composition of active ingredients optimized for targeted therapy.
- Claims cover both the formulation and methods of treatment, with emphasis on particular ratios and delivery modes.
- The patent landscape includes multiple filings with overlapping claims but distinct innovations in formulation and uses.
- No significant enforcement actions or challenges are publicly recorded as of now.
- Expiry in 2034 provides a substantial market window, assuming commercialization proceeds as planned.
FAQs
Q1: Are there similar patents for the same therapeutic area?
Yes, multiple patents cover related active ingredients and formulations, with some overlapping claims in neuropharmacology and combination therapies.
Q2: Can this patent be challenged or designed around?
Potentially, if alternative formulations or delivery methods are developed that avoid the specific ratios and claims of the patent.
Q3: How does the patent impact competitive R&D?
It provides a protected space for specific combination therapy development within the scope of its claims through 2034, discouraging generic entry and encouraging innovation around its formulations.
Q4: What are the key patent drafting strengths?
Detailed formulation ranges and method claims broaden the scope beyond the composition alone, making it harder for competitors to design around.
Q5: What regulatory considerations could influence patent valuation?
Approval pathways, patent term extensions, and clinical trial data will impact the commercial value and enforceability of the patent.
References
[1] USPTO Patent Database. Patent 10,159,759.
[2] European Patent Office (EPO). Patent family information.
[3] Patent landscape reports from industry analysts.
